Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke

Study:

A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke

Rationale:

n/a

Purpose:

The primary objective of this study is to compare the efficacy of ONO-2506 versus placebo in neurological stroke outcome in patients with acute ischemic stroke.

Study Status: Terminated

Recruiting:
n/a

Condition Intervention Phase
Cerebrovascular Accident Drug: ONO-2506 Phase 2/Phase 3

Verified by Ono Pharma USA Inc October, 2012

Sponsored by: Ono Pharma USA Inc
Information provided by: Ono Pharmaceutical Co. Ltd
ClinicalTrials.gov identifier: NCT00046761

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Cleveland Clinic Florida
Weston, Florida 33331
United States

Bryan Due, Ph.D.., Study Director

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site